Our research activity focuses on the development of advanced molecular diagnostics technologies and point-of-care devices for early detection and management of diseases. Our highly multidisciplinary research activities combines the fundamental and translational studies at the interface between chemistry, physics, nanotechnology, and biology.
130
Publications
$5.5M
Total Funding
3,825
Citation Count
341
Verified Review
Latest Research
Nanomachineries for Exosomes and Exosomal Biomarkers Analysis

The Shiddiky Laboratory is pursuing studies of the development of multifunctional magnetic nanomaterials based novel nanomachineries for the highly selective isolation and sensitive detection of exosome and exosomal biomarkers in patients with cancer and other diseases.

Read More About Nanomachineries

Nanomachineries for Exosomes and Exosomal Biomarkers Analysis
‘Metal-Biomolecules’ Affinity Interaction for Genetic, Epigenetic, and Proteomic Biomarkers

A novel platform method based on metal-biomolecules affinity interaction (i.e., adsorption) for the analysis of a range of genetic, epigenetic, and proteomic biomarkers in patients with cancers and other diseases. This method can overcome the major technological drawbacks in current biosensing approaches.

Read More About Nanobiosensing

‘Metal-Biomolecules’ Affinity Interaction for Genetic, Epigenetic, and Proteomic Biomarkers
Twitter Feed

Very excited to be part of this project funded by #MRFF and @nhmrc on #ovariancancer #exosomes #nanoparticles with my long time collaborator @cfsalomo Looking forward to our collaborations with @popatlab @UQPharmacy @UQMedicine @Griffith_Health @GriffithUniNews @GU_Sciences

I'm thrilled for the opportunity to develop this project - great team effort @ExosomeLab @popatlab @Shiddiky_Aus @yusuke_yamauchi thanks @ausgov @GregHuntMP for the trust in our work #Uqccr - big thanks @ocrfaustralia @UQMedicine https://twitter.com/exosomelab/status/1264737746091819008

Load More...